Can CAR T cell therapy be considered for heart transplant recipients with concurrent lymphoproliferative disorders?
1 Answers
Mednet Member
Cardiology · University of Nebraska Medical Center
The short version of my answer is: Possibly Yes.
There is a very limited evidence from the literature in this topic, however, I will base my explanation on the following case reports: McKenna et l., PMID 37129856, Dang et al., PMID 33002249, Portuguese et al., PMID 36575360.
The provided case reports...